• Sign In
  • Sign Up
    Loading ...
View All Updates Mark All Read
THE FREE WORLD PRESS ~ Paul Coulbeck, Chatham-Kent--Leamington Marijuana Party
  • Home
  • Members
  • Albums
  • Classifieds
  • Blogs
  • Polls
  • Forum
  • Chat
  • Groups
  • Events
  • Videos
  • Music

Member Info

  • Profile Type: Regular Member
  • Profile Views: 1,951 views
  • Friends: 0 friends
  • Last Update: January 18, 2023
  • Joined: May 2, 2022
  • Updates
  • Info
  • Albums(2)
  • Blogs(50)
  • Forum Posts(28)

Updates

The post was not added to the feed. Please check your privacy settings.
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Digital PCR Market Potential Growth& Forecasts to 2032
    Digital PCR has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of disease diagnosis. Most players in the global digital PCR market offer products, such as kits and assays, systems, and reagents and...  moreDigital PCR has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of disease diagnosis. Most players in the global digital PCR market offer products, such as kits and assays, systems, and reagents and consumables.
    The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development.
    Impact of COVID-19
    The current global digital PCR market comprises kits and assays, system, and reagents and consumables. The unexpected crisis of the pandemic has surged the demand for essentials and increased the demand for digital PCR products. There was increased demand...    less
    • January 18, 2023
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Cell and Gene Therapy Market Current Growth
    Cell and gene therapy are overlapping fields of biomedical research having similar therapeutic goals, which target DNA or RNA inside or outside the body. Both therapies aim at modifying genetic material for treatment of a disease. Gene therapy uses...  moreCell and gene therapy are overlapping fields of biomedical research having similar therapeutic goals, which target DNA or RNA inside or outside the body. Both therapies aim at modifying genetic material for treatment of a disease. Gene therapy uses genetic material, or DNA, to manipulate a patient’s cells for the treatment of an inherited or acquired disease. Cell therapy is the introduction of new cells into a patient’s body to grow, replace or repair damaged tissue to treat a disease. The cell and gene therapies are categorized into several therapeutic class, such as rare diseases, oncology, hematology, cardiovascular, ophthalmology, neurology, and others.
    The global cell and gene therapy market was valued at $2,599.7 million in 2020, and it is expected to grow at an impressive double-digit rate of 33.82% and reach a value of $25,002.1 million in 2027.
    The existing cell and gene therapy market is favored by multiple factors, which include increasing incidences of cancer and...    less
    • December 29, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Endoscopic Imaging Systems Market Future Outlook 2030
    The adoption of artificial intelligence (AI) in endoscopic procedures and the entry of local companies into the regional endoscopic imaging systems market are significant opportunities in the global endoscopic imaging systems market. Moreover, the...  moreThe adoption of artificial intelligence (AI) in endoscopic procedures and the entry of local companies into the regional endoscopic imaging systems market are significant opportunities in the global endoscopic imaging systems market. Moreover, the increasing demand in developing regions is also an opportunity for market growth.
    The global endoscopic imaging systems market is projected to reach $6.94 billion in terms of revenue by 2030, at a CAGR of 7.43%, suggests the premium market intelligence study by BIS Research.
    The comprehensive study of the global endoscopic imaging systems market by BIS Research extensively covers the market numbers based on the types of applications and region. It analyzes 15 companies offering endoscopic imaging systems along with a detailed global and regional market analysis, including the scrutiny of 10 key countries.
    Recent Developments in Global Endoscopic Imaging Systems Market
    •    In October 2021, Fujifilm Healthcare...    less
    • December 16, 2022
  • BIS Reports
    BIS Reports added 1 photo(s) to the album Research Reports:
    • December 16, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    PD-1/PDL-1 Inhibitor Market Growth Estimate & Strategy
    Programmed cell death 1 (PD-1) inhibitor and programmed death ligand 1 (PD-L1) inhibitor are therapeutic agents that inhibit binding together of these checkpoint proteins on immune cells, eventually preventing tumors to escape the host immune defense...  moreProgrammed cell death 1 (PD-1) inhibitor and programmed death ligand 1 (PD-L1) inhibitor are therapeutic agents that inhibit binding together of these checkpoint proteins on immune cells, eventually preventing tumors to escape the host immune defense mechanism and control the disease progression.
    The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient.
    PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor...    less
    • December 15, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    AI in Healthcare Market Growth Analysis
    AI-enabled devices are used for augmenting care delivery, data management, diagnosis, and research, among other healthcare operations. Various technologies such as big data, augmented intelligence, multi-model data management, and artificial intelligence...  moreAI-enabled devices are used for augmenting care delivery, data management, diagnosis, and research, among other healthcare operations. Various technologies such as big data, augmented intelligence, multi-model data management, and artificial intelligence (AI), are being used for efficient data management. However, AI adoption is anticipated to be highest among all the data management technologies. Moreover, AI technology is anticipated to enhance the efficacy of clinician workflow, decision-making process, and administration workflow. 
    The global AI in healthcare market is anticipated to reach $35,892.2million by 2030, registering a CAGR of 24.40%, during the forecast period 2021-2030. Owing to the COVID pandemic, the market grew with a significant growth rate in 2020. The global lockdown and social distancing norms highlighted the importance of remote monitoring, telemedicine, and technology integration in the primary healthcare system, which accelerated the market growth in 2020. The...    less
    • December 8, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Human Identification Market Growth and Recent Trends
    In forensics, paternity testing, identifying disaster victims, and anthropology, among other fields, human identification is frequently used, and DNA analysis and profiling is a crucial tool in this field. Human identification and forensics labs are...  moreIn forensics, paternity testing, identifying disaster victims, and anthropology, among other fields, human identification is frequently used, and DNA analysis and profiling is a crucial tool in this field. Human identification and forensics labs are constantly under pressure to improve the efficiency of their workflows without compromising quality due to rising time and resource demands. The fundamental concepts of each step in criminal investigation and paternity determination are illustrated by examining the variety of biological indicators that are available to investigators. The preferred forms of identification, DNA and fingerprints, necessitate a prior history and a verifiable baseline for comparison.
    The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032. The growth in the global human identification market is expected to be driven by the increasing adoption of NGS in...    less
    • December 2, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Molecular Diagnostics Market Forecast by 2031
    Diagnostic tests provide critical insights at every stage of medical care - right from the genetic tests providing information about personalized cancer treatment to the microbial culture identifying accurate antibiotics against an infection. The...  moreDiagnostic tests provide critical insights at every stage of medical care - right from the genetic tests providing information about personalized cancer treatment to the microbial culture identifying accurate antibiotics against an infection. The importance of diagnostic tests throughout the entire procedure (i.e., prevention, detection, diagnosis, treatment, and successful management of health conditions) of treating an individual for a particular disease is as consequential as the treatment itself. It has been subjected to extensive research for further refinement of the same.
    Our healthcare experts have found the molecular diagnostics market to be one of the stable markets, and the global market is predicted to grow from $10,914.6 million in 2020 to $24,228.0 million in 2031 and is expected to grow with a CAGR of 7.38% during the forecast period 2021-2031.
    Factors fueling the growth of the market include a highly increasing prevalence of infectious diseases and various types of cancer, an...    less
    • November 25, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Serum-Free Media Market Analysis & Future Scope
    The global serum-free media market is progressing rapidly with a significant increase in research and development activities pertaining to a wide range of animal component-free products for disease detection, accentuating their criticality in healthcare....  moreThe global serum-free media market is progressing rapidly with a significant increase in research and development activities pertaining to a wide range of animal component-free products for disease detection, accentuating their criticality in healthcare. Serum-free media has a critical role in the cellular diagnostics approach, as it ensures the safe and effective application for improved cell culture and cell therapy-based methods.
    The global serum-free media market was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032. The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media, rising awareness of media-based diagnostic testing, and significant number of funding for executing research and development.

     
    Recent Developments in the Global Serum-Free Media Market
    •    In August 2022, Thermo...    less
    • November 21, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    OR Management Solutions Market Size, Growth, Industry Trends
    The global operating room (OR) management solutions market is a significant market that includes a wide range of software solutions used in an operating room. These include, among other things, solutions for data management, inventory management, surgery...  moreThe global operating room (OR) management solutions market is a significant market that includes a wide range of software solutions used in an operating room. These include, among other things, solutions for data management, inventory management, surgery scheduling and planning, communication among surgical staff both inside and outside the OR, and improved visualisation, reporting, and documentation.
    The global operating room management solutions market report highlights that the market was valued at $2,023.5 million in 2021 and is expected to reach $3,699.1 million by the end of 2031. The market is expected to grow at a CAGR of 6.29% during the forecast period from 2022 to 2031.
     
    Impact of COVID-19 on the Operating Room Management Solutions Market
    The COVID-19 pandemic led to a deferral of elective surgeries across various clinical areas, such as neurology and cardiology. The pandemic also placed heightened importance on the safety and sterilization protocols followed by the medical...    less
    • November 11, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Biomaterials Market New Industry Dynamics
    A biomaterial is any substance that has been engineered to be biocompatible for interaction with biological systems. There are two types of biomaterials: synthetic and natural. Metals, polymers, and ceramics make up synthetic materials, whereas natural...  moreA biomaterial is any substance that has been engineered to be biocompatible for interaction with biological systems. There are two types of biomaterials: synthetic and natural. Metals, polymers, and ceramics make up synthetic materials, whereas natural biomaterials are derived from natural sources such as animal tissues or engineered in the laboratory. Some tissues are obtained from animals such as cows or pigs. The interaction of these biomaterials with the human body aids in the treatment, augmentation, repair, or replacement of a bodily tissue function.
    The global biomaterials market was valued at $122.92 billion in 2020 and is expected to reach $725.88 billion by 2031, growing at a CAGR of 17.98% between 2021 and 2031. The biomaterials market is driven by a number of factors such as superior properties of biomaterials, increasing funds/aids by the government for research purposes, increasing wound healing therapies plastic surgeries, increasing aging/geriatric population, rise in...    less
    • November 3, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    3D Protein Structure Analysis Market Growth Analysis
    Global 3D protein structure analysis market is a well-established market and is expected to grow further in the coming years due to the continuous technological advancements in equipment for protein structure analysis along with the increase in the use...  moreGlobal 3D protein structure analysis market is a well-established market and is expected to grow further in the coming years due to the continuous technological advancements in equipment for protein structure analysis along with the increase in the use of small angle X-Ray scattering (SAXS) technique for 3D protein structure analysis.
    In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032. The growth in the global 3D protein structure analysis market is expected to be driven by technological advancements in equipment for protein structure analysis and by an increase in RD expenditure to accelerate protein structure analysis.

     
    Recent Developments in Global 3D Protein Structure Analysis Market
    •    In February 2022, JEOL Ltd. announced the development of a new cold field emission cryo-electron microscope (cryo-EM),...    less
    • October 18, 2022
  • BIS Reports
    BIS Reports shared BIS Reports's image.
    In-orbit Refueling: In-Space Economy & Emerging Growth Opportunities

    Wondering how the in-space economy is going to evolve and what will be the significance of in-orbit refueling services in that regard?
    BIS Research is organizing an extensive #webinar...  more    In-orbit Refueling: In-Space Economy & Emerging Growth Opportunities

    Wondering how the in-space economy is going to evolve and what will be the significance of in-orbit refueling services in that regard?
    BIS Research is organizing an extensive #webinar on "In-Orbit Space Refueling" that will answer all your questions.
    The webinar will be hosted by the team of lead research analysts (Aerospace & SpaceTech) at BIS Research, along with our guest presenter Daniel Faber, CEO of Orbit Fab. Learn from the industry leaders about the significance of in-orbit refueling, docking systems, refueling ports, situational awareness, standardization in manufacturing, risks and barriers, and more.
    https://bit.ly/3CpLoSG  less
    • October 14, 2022
    • BIS Reports likes this.
  • BIS Reports
    BIS Reports In-orbit Refueling: In-Space Economy & Emerging Growth Opportunities

    Wondering how the in-space economy is going to evolve and what will be the significance of in-orbit refueling services in that regard?
    BIS Research is organizing an extensive #webinar...  more    In-orbit Refueling: In-Space Economy & Emerging Growth Opportunities

    Wondering how the in-space economy is going to evolve and what will be the significance of in-orbit refueling services in that regard?
    BIS Research is organizing an extensive #webinar on "In-Orbit Space Refueling" that will answer all your questions.
    The webinar will be hosted by the team of lead research analysts (Aerospace & SpaceTech) at BIS Research, along with our guest presenter Daniel Faber, CEO of Orbit Fab. Learn from the industry leaders about the significance of in-orbit refueling, docking systems, refueling ports, situational awareness, standardization in manufacturing, risks and barriers, and more.
    https://bit.ly/3CpLoSG  less
    • October 14, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Hyperspectral Imaging Market Growing Opportunities
    The market for hyperspectral technology is continually developing. The creation of more hyperspectral imaging products is being pursued through increased research and development efforts.
    A few of the key opportunities in the worldwide hyperspectral...  more    The market for hyperspectral technology is continually developing. The creation of more hyperspectral imaging products is being pursued through increased research and development efforts.
    A few of the key opportunities in the worldwide hyperspectral imaging market are the growing technical developments in hospitals, diagnostic centres, military and defence industries, agricultural practises, and research facilities. Additionally, the expanding demand in developing nations presents a chance for the industry to expand.
    The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining.
     
    COVID-19 Impact and Post-COVID-19 Scenario
    The COVID-19 pandemic had a debilitating impact on the global...    less
    • October 3, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Hyperspectral Imaging Market Business opportunities
    The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense...  moreThe hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.
    The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining.
     
    COVID-19 Impact and Post-COVID-19 Scenario
    The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on several markets....    less
    • September 28, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Cell-Free RNA Isolation and Extraction Kits Market
    The industry for cell-free RNA isolation and extraction kits is significant, and it plays an important role in data collection for a number of treatment techniques, highlighting its importance in the healthcare business. Cell-free RNA is crucial to the...  moreThe industry for cell-free RNA isolation and extraction kits is significant, and it plays an important role in data collection for a number of treatment techniques, highlighting its importance in the healthcare business. Cell-free RNA is crucial to the precision medicine strategy because it guarantees the effective and safe use of targeted medicines. The majority of companies selling products on the global market for cell-free RNA isolation and extraction kits do so.
    Increasing investments in the R&D for cell-free RNA isolation and extraction is one of the major opportunities in the global cell-free RNA isolation and extraction kits market. Several biotechnology and pharmaceutical companies are working collaboratively to adopt cell-free RNA isolation and extraction in the field of oncology, prenatal screening, and metabolic disorders.
    The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of...    less
    • September 26, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Plasma Medicine Market Strategies and Implementation
    Today, plasma medicine application is already saving lives and driving billions of dollars of economic activity. Advances in plasma medicine technology, computational and analytical capabilities, and non-invasive diagnostic processes have reduced the...  moreToday, plasma medicine application is already saving lives and driving billions of dollars of economic activity. Advances in plasma medicine technology, computational and analytical capabilities, and non-invasive diagnostic processes have reduced the cost and diagnostic time, thus eliminating the major restraints for the implementation of precision medicine.
    Plasma medicine is a growing field combining plasma physics, biology, and clinical medicine and has an impact in several important areas in therapeutic patient care, combining plasma physics, biology, and clinical medicine. Earlier, plasmas in medicine were used in non-contact hemostasis and electrosurgery for cautery, while presently, non-thermal plasmas have attained widespread use in medicine due to their effectiveness and compatibility with biological systems. The most active areas of plasma technology applications are in the inactivation of pathogens, wound treatment, treatment of skin disorders, tissue regeneration, and sterilization. There...    less
    • September 22, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Pharmaceutical Aseptic Transfer Market Industry Growth
    According to the study, the global pharmaceutical aseptic transfer market was $855.2 million in 2021 and is projected to reach $2.55 billion by 2031.

    The following factors are responsible for the increase in demand for...  more    According to the study, the global pharmaceutical aseptic transfer market was $855.2 million in 2021 and is projected to reach $2.55 billion by 2031.

    The following factors are responsible for the increase in demand for pharmaceutical aseptic transfer:

    Rapid expansion of the pharmaceutical industry
    Significant rise in investment in the pharmaceutical industry
    Implementation of stringent regulations for drug approval processes
    Growing demand for automated products for aseptic transfer processes

    The detailed study is a compilation of 27 market data tables and 226 figures spread through 270 pages. 
    Check out the detailed table of content here →  https://bisresearch.com/requestsample?id=1344type=toc
    Impact of COVID-19
    The COVID-19 pandemic led to pharmaceutical companies investing heavily in RD and ramping up production of potentially life-saving drugs for COVID-19. The unprecedented demand for these drugs and the urgency to cater to the demand...    less
    • September 20, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Radioligand Therapy Market Future Analysis
    Radioligand therapeutics, also known as radiopharmaceuticals, which show antitumor effects, has seen rapid development over the past decade. Although some therapies are already approved for human use, many more are in the clinical trial and will enter...  moreRadioligand therapeutics, also known as radiopharmaceuticals, which show antitumor effects, has seen rapid development over the past decade. Although some therapies are already approved for human use, many more are in the clinical trial and will enter clinical practice in the next 2-7 years, potentially introducing new therapeutic choices for patients. Despite this innovation, several challenges remain, including supply chain, logistics, regulatory issues, and education and training. 
    The current market for radioligand therapy is majorly dominated by manufacturers such as Novartis AG, Pfizer Inc, Johnson & Johnson Services, Inc, Telix Pharmaceuticals, Lantheus Holdings Inc., (Progenics Pharmaceuticals), Molecular Partners AG, Clovis Oncology Inc., Fusion Pharma, Point Biopharma, Precirix, ITM Isotope Technologies Munich SE, Curium Pharma, and RadioMedix. 
    The global radioligand therapy market was valued at $9.75 billion in 2020 and is projected to reach $16.65 billion by 2031,...    less
    • September 13, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Narcolepsy Therapeutics Market Key Findings and Forecast
    The global narcolepsy therapeutics market is in the rapidly evolving and dynamic stage, which opens ample opportunities for life science companies. Also, companies that are already in the development phase for narcolepsy therapies are trying to bring...  moreThe global narcolepsy therapeutics market is in the rapidly evolving and dynamic stage, which opens ample opportunities for life science companies. Also, companies that are already in the development phase for narcolepsy therapies are trying to bring advanced treatment options to the market to improve the quality of life of people with narcolepsy. The companies operating in the global narcolepsy therapeutics market are now focusing more on disease-specific and personalized treatment options. Also, major players such as Jazz Pharmaceuticals PLC, Takeda Pharmaceuticals Co. Ltd, and Bioproject Pharma are investing heavily in research and development for their respective therapeutic products.
    The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032. This The market is driven by certain factors, such as low satisfaction with available therapies, robust pipeline products, rising...    less
    • August 31, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Digital Biomanufacturing Market Strategy and Forecast to 2031
    The innovations of digital technologies have introduced various levels of shifts in manufacturing sectors. The digitalization waves have supported a wide range of applications, from upstream supply chain management to post-manufacturing product tracing...  moreThe innovations of digital technologies have introduced various levels of shifts in manufacturing sectors. The digitalization waves have supported a wide range of applications, from upstream supply chain management to post-manufacturing product tracing and tracking.The global digital biomanufacturing market will be witnessing growth due to the inclusion of new technology trends. Any new market players that enter the market will have to have these technologies to compete in the market and to make a place and gain a strong hold.
    The global  digital biomanufacturing market  report highlights that the market was valued at $15,768.9 million in 2021 and is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031 .
    Global Digital Biomanufacturing Market, $Million, 2020, 2021, and 2031

    Source: Expert Interviews and BIS Research Analysis
    Market Segmentation
    Global Digital Biomanufacturing Market...    less
    • August 26, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Ligase Market Developments and Future Research Report
    The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a...  moreThe global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes.
    The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.
     

    Impact
    Several techniques are employed in the development of...    less
    • August 23, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Natural Killer (NK) Cell Therapeutics Market Future Scope
    The increasing interest of the pharmaceutical industry in cellular immunotherapy potential has been a catalyst for the progress in the global NK cell therapeutics market. The pharmaceutical industry is currently dominated by other immunotherapies such as...  moreThe increasing interest of the pharmaceutical industry in cellular immunotherapy potential has been a catalyst for the progress in the global NK cell therapeutics market. The pharmaceutical industry is currently dominated by other immunotherapies such as CAR T-cell therapies, checkpoint inhibitors, and cytokines. However, the proportion of natural killer (NK) cell therapeutics is anticipated to increase given the ability to fulfill unmet medical needs, overcome limitations associated with existing immunotherapies, and address complex, challenging targets.
    The global Natural Killer (NK) cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032. The growth in the global NK cell therapeutics market is expected to be driven by the rising in the number of clinical trials and the increasing incidence and prevalence of cancer cases.

    Impact of COVID-19
    Due to the pandemic, governments across the...    less
    • August 21, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Hematological Malignancies Emerging Therapeutics Market Insight
    The hematological malignancies emerging therapeutics market growth has been primarily attributed to major drivers in this market, such as growing prevalence of hematological malignancies, favorable regulatory environment, and increase in adoption of...  moreThe hematological malignancies emerging therapeutics market growth has been primarily attributed to major drivers in this market, such as growing prevalence of hematological malignancies, favorable regulatory environment, and increase in adoption of precision medicine in the field of hematological malignancies. However, there are significant challenges restraining the market growth. These challenges include the high cost hindering the adoption rate, unfavorable reimbursement scenario, and safety concerns pertaining to severe adverse effects.
    The hematological malignancies emerging therapeutics market report provides a holistic view of the market in terms of various factors influencing it, including reported clinical findings, financing and partnership opportunities, expected market, and current clinical landscape.
    The global hematological malignancies emerging therapeutics market analysis by BIS Research projects the industry to grow at a significant CAGR of 14.20% during the forecast period...    less
    • August 17, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Nucleic Acid Therapeutics CDMO Market Growth Analysis
    The completion of human genome sequencing and the elucidation of the molecular pathways that are critical in the disease molecule interaction have offered an unprecedented opportunity and growth for the development of nucleic acid-based therapeutics....  moreThe completion of human genome sequencing and the elucidation of the molecular pathways that are critical in the disease molecule interaction have offered an unprecedented opportunity and growth for the development of nucleic acid-based therapeutics. However, to keep with the manufacturing and development of such therapies, the pharmaceutical companies have established partnerships with the contract development and manufacturing company (CDMO) which are the viable alternatives to the in-house development of the drugs. Moreover, the success of the respective business model has also led these CDMOs to become an integral part of such pharmaceutical companies’ value chain.
    The increasing willingness to outsource drug development to the CDMOs, and the rising need for pharmaceuticals have resulted in the expansion of the global market for nucleic acid therapeutics CDMO.The global nucleic acid therapeutics CDMO market is expected to reach $4,463.7 Million by 2030, with a CAGR of 11.09 %...    less
    • August 9, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    MRD Testing Market Insights & Outlook 2027
    The global MRD testing market is in the rapidly evolving and dynamic stage, which opens ample opportunities for diagnostic and life science companies. MRD testing promises the integration of evolutionary molecular technologies into hematological...  moreThe global MRD testing market is in the rapidly evolving and dynamic stage, which opens ample opportunities for diagnostic and life science companies. MRD testing promises the integration of evolutionary molecular technologies into hematological malignancy care regimens, thereby driving tremendous growth in the overall hematological malignancies testing market.The  minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%. The market is driven by certain factors, such as the rising incidence of hematologic malignancies, increasing consumer awareness for tailored therapy, increasing research funding from the National Cancer Institute and increasing disposable income in emerging economies.

    Impact
    With an increased worldwide focus on treating hematological malignancies, the major market players are developing novel diagnostic tests, which are significantly impacting the growth of the MRD testing...    less
    • August 8, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Liquid Biopsy Market Growth Opportunity And Forecast to 2032
    Liquid biopsy has a critical role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics. A liquid biopsy helps physicians to analyze tumor-related information through a simple blood test. As...  moreLiquid biopsy has a critical role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics. A liquid biopsy helps physicians to analyze tumor-related information through a simple blood test. As researchers are generating data that have the potential to lead to unprecedented biological insight, albeit at the cost of the greater complexity of data analysis. Increasing investments in RD of liquid biopsy products and services and various research fundings is one of the major opportunities in the global liquid biopsy market.
    The global liquid biopsy market was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032. The growth in the global liquid biopsy market is expected to be driven by increasing adoption of NGS in various research fields, advancement in NGS, and increase in the adoption of personalized medicine.

    Impact of COVID-19
    The current global liquid biopsy...    less
    • August 3, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Digital Biomarkers Market Analysis and Forecast, 2022-2028
    Today, digital biomarkers are frequently used for diagnosis and follow-up within therapy. They are objective, quantitative aspects of biological processes that are linked to medical indications, symptoms, surrogate endpoints, and clinical endpoints....  moreToday, digital biomarkers are frequently used for diagnosis and follow-up within therapy. They are objective, quantitative aspects of biological processes that are linked to medical indications, symptoms, surrogate endpoints, and clinical endpoints. There are multiple undergoing studies on how heterogeneous data may be accessible to deduce equivalents to conventional biomarkers when it comes to digital health and the use of smart devices that enable pervasive sensing of surrounding factors such as vital signs. Digital biomarkers have multiple applications across the healthcare industry, and an increasing adoption rate has been observed over the past few years.
    During the COVID-19 pandemic, technological advancements such as the integration of software and artificial intelligence (AI) in wearable devices, rising adoption of mHealth applications, and growing interest in telemedicine and remote patient monitoring systems have all contributed to the market growth for digital biomarkers. The...    less
    • July 28, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Viral Vector and Plasmid Manufacturing Market Forecsat
    The global viral vector and plasmid manufacturing market represents the market scenario of the viral vector and plasmid products and services across the world, taking into account key companies and their offerings in the market.
    The advent of advanced...  more    The global viral vector and plasmid manufacturing market represents the market scenario of the viral vector and plasmid products and services across the world, taking into account key companies and their offerings in the market.
    The advent of advanced therapies including gene therapy and cell therapy, which employ the use of vectors has created a huge buzz in the field of medicine in the past few decades. Therapies that require genetic modification, including the introduction of therapeutic DNA/gene into a patient's body or cell, demonstrated tremendous potential for the treatment of several critical diseases, including cancer, Alzheimer's disease, Parkinson's disease, and rheumatoid arthritis, among others.
    The global viral vector and plasmid manufacturing market was estimated to reach $5.86 billion in 2030 , growing at a significant CAGR of 16.28% during the forecast period from 2020 to 2030.
    Growth Factors

    Rising prevalence of cancer, genetic disorders, and infectious...    less
    • July 28, 2022
  • BIS Reports
    BIS Reports posted a topic in the forum News and Announcements:
    Narcolepsy Therapeutics Market Strategies
    The global narcolepsy therapeutics market is in the rapidly evolving and dynamic stage, which opens ample opportunities for life science companies. Also, companies that are already in the development phase for narcolepsy therapies are trying to bring...  moreThe global narcolepsy therapeutics market is in the rapidly evolving and dynamic stage, which opens ample opportunities for life science companies. Also, companies that are already in the development phase for narcolepsy therapies are trying to bring advanced treatment options to the market to improve the quality of life of people with narcolepsy. The companies operating in the global narcolepsy therapeutics market are now focusing more on disease-specific and personalized treatment options. Also, major players such as Jazz Pharmaceuticals PLC, Takeda Pharmaceuticals Co. Ltd, and Bioproject Pharma are investing heavily in research and development for their respective therapeutic products.
    The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032. This The market is driven by certain factors, such as low satisfaction with available therapies, robust pipeline products, rising...    less
    • July 27, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Pharmacogenomics Services Market Analysis & Forecast 2031
    Pharmacogenomics Services Market Analysis & Forecast 2031
    Pharmacogenomics has increasingly become an area of interest for the research community, which has the potential to revolutionize precision care, largely due to the studies that focus on the discovery of biomarkers associated with a particular medical con...
    • July 26, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Carrier Screening Market Status Outlook 2031
    Carrier Screening Market Status Outlook 2031
    The carrier screening market is an emerging market with huge growth potential. Carrier screening tests are extensively used by couples considering becoming pregnant to determine the risks of passing genetic anomalies to the child. This study aims at ...
    • July 21, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Blood and Plasma Components Market Future Opportunities by 2031
    Blood and Plasma Components Market Future Opportunities by 2031
    The global blood and plasma components market is expected to witness minimal growth, attributing to the rising burden of primary immunodeficiency diseases such as hemophilia A, von Willebrand disease (vWD), and secondary immunodeficiency diseases. Further...
    • July 19, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    NGS Oncology Market Offers High Revenue Growth 2032
    NGS Oncology Market Offers High Revenue Growth 2032
    The NGS oncology market is a well-developed market with an integral part of medical decision-making, which aid in acquiring information for a wide range of treatment dissemination, accentuating their criticality in healthcare. The NGS oncology has a criti...
    • July 18, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Europe Infectious Disease Diagnostics Market Analysis
    Europe Infectious Disease Diagnostics Market Analysis
    The use of infectious disease diagnostics kits, assays, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives. The increasing investments by healthcare comp...
    • July 15, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Global mRNA Vaccines and Therapeutics Market Growth Analysis
    Global mRNA Vaccines and Therapeutics Market Growth Analysis
    The global mRNA vaccines and therapeutics market for COVID-19 vaccines and non-COVID-19 vaccines is projected to reach $28.92 billion and $1.69 billion by 2025 and 2031, respectively, reveals the premium market intelligence study by BIS Research...
    • July 14, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Pharmaceutical Quality Management Software Market Analysis
    Pharmaceutical Quality Management Software Market Analysis
    The manufacture of drugs and pharmaceutical products passes through various processing steps, each of which requires monitoring to ensure the safety, efficacy, and quality of the manufactured product. Traditional paper-based quality management systems are...
    • July 13, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Preimplantation Genetic Testing Market Analysis & Dynamics 2031
    Preimplantation Genetic Testing Market Analysis & Dynamics 2031
    The preimplantation genetic testing is set to grow at a significant rate in the upcoming years as the technology and awareness regarding the test improve.
    Preimplantation genetic diagnosis (PGD) is performed among couples that have a higher risk of trans...
    • July 13, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Medical Grade Tubing Market to Hit US$ $6,255.9 million by 2030
    Medical Grade Tubing Market to Hit US$ $6,255.9 million by 2030
    The market for medical grade tubing is rapidly growing, with products used in medical applications such as drug delivery, IV tubing, catheters, and bulk disposable tubing. With the growing incorporation of medical tubing in various medical technologies, m...
    • July 13, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Axial Spondyloarthritis Market Growth Analysis & Forecast
    Axial Spondyloarthritis Market Growth Analysis & Forecast
    Biopharmaceutical companies are trying to match themselves with new technologies in the market to improve the overall system from drug discovery to drug commercialization.The companies operating in the global axial spondyloarthritis market are now focusin...
    • July 8, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Big Data in Healthcare Market Analysis & Forecast to 2031
    Big Data in Healthcare Market Analysis & Forecast to 2031
    Big data is one of the subjects of interest since it has the potential to transform modern healthcare. The technology has grown substantially over the last two decades. Many healthcare companies have begun to leverage big data for a variety of application...
    • June 22, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Spine X-Ray and Computed Tomography (CT) Market Analysis & Fore
    Spine X-Ray and Computed Tomography (CT) Market Analysis & Fore
    The market for spine X-ray and CT devices is rapidly growing, with an increasing number of X-rays and CT scans used in imaging of vertebral fractures, spinal infections, and spinal tumors, among others. Furthermore, the integration of AI in imaging has ac...
    • June 20, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Precision Cardiology Market Analysis and Forecast, 2031
    Precision Cardiology Market Analysis and Forecast, 2031
    Precision cardiology market’s growth is highly dependent upon the growth of molecular reproductive genetic testing as well as hereditary genetic testing. A large number of gene variants continue to have unknown significance with regard to CVDs ...
    • June 20, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Lung Cancer Genomic Testing Market Analysis & Forecast 2031
    Lung Cancer Genomic Testing Market Analysis & Forecast 2031
    The global lung cancer genomic testing market is still in the nascent phase. Various companies are increasing investments in research and development to facilitate the development of lung cancer genomic testing, which is expected to further increase the a...
    • June 17, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Minimally Invasive Surgical Systems Market Analysis & Forecast
    Minimally Invasive Surgical Systems Market Analysis & Forecast
    As per the U.S. Food and Drug Administration (FDA), “Different types of computer-assisted surgical systems can be used for pre-operative planning, surgical navigation, and to assist in performing surgical procedures. Robotically assisted surgical (R...
    • June 15, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    U.S. Solid Tumor Testing Market Trend and Forecast 2032
    U.S. Solid Tumor Testing Market Trend and Forecast 2032
    The U.S. solid tumor testing market is progressing rapidly. Significant increases in the research and development activities pertaining to solid tumor testing are underway to develop better testing kits and assays, which are expected to increase due to th...
    • June 15, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    MRD Testing Market Status and Outlook
    MRD Testing Market Status and Outlook
    The global MRD testing market is in the rapidly evolving and dynamic stage, which opens ample opportunities for diagnostic and life science companies. Also, companies that are already in the development phase for MRD tests are trying to match themselves w...
    • June 15, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Next-Generation Gynecological Cancer Diagnostics Market Analysi
    Next-Generation Gynecological Cancer Diagnostics Market Analysi
    Ovarian, cervical, and uterine cancer are the most common gynecological malignancies among women worldwide. Cervical cancer is the fourth most frequently occurring cancer in women. It is anticipated that cervical cancer cases will increase from approximat...
    • June 10, 2022
  • BIS Reports
    BIS Reports wrote a new blog entry:
    Spine X-Ray and Computed Tomography (CT) Market Growth Analysis
    Spine X-Ray and Computed Tomography (CT) Market Growth Analysis
    The market for spine X-ray and CT devices is rapidly growing, with an increasing number of X-rays and CT scans used in imaging of vertebral fractures, spinal infections, and spinal tumors, among others. Furthermore, the integration of AI in imaging has ac...
    • June 7, 2022
View More
Loading ...

Info

Personal Information

  • First Name BIS
  • Last Name Reports
  • Gender Female
  • Birthday November 19, 2000

Albums

  • Research R­eports 1 photo

  • Wall Photo­s 2 photos

Previous
Next

Blogs

  • Pharmacogenomics Services Market Analysis & Forecast 2031

    Posted July 26, 2022

    Pharmacogenomics has increasingly become an area of interest for the research community, which has the potential to revolutionize precision care, largely due to the studies that focus on the discovery of biomarkers associated with a particular medical condition. This st...

  • Carrier Screening Market Status Outlook 2031

    Posted July 21, 2022

    The carrier screening market is an emerging market with huge growth potential. Carrier screening tests are extensively used by couples considering becoming pregnant to determine the risks of passing genetic anomalies to the child. This study aims at deciphering the...

  • Blood and Plasma Components Market Future Opportunities by 2031

    Posted July 19, 2022

    The global blood and plasma components market is expected to witness minimal growth, attributing to the rising burden of primary immunodeficiency diseases such as hemophilia A, von Willebrand disease (vWD), and secondary immunodeficiency diseases. Further, the increasin...

  • NGS Oncology Market Offers High Revenue Growth 2032

    Posted July 18, 2022

    The NGS oncology market is a well-developed market with an integral part of medical decision-making, which aid in acquiring information for a wide range of treatment dissemination, accentuating their criticality in healthcare. The NGS oncology has a critical role in the...

  • Europe Infectious Disease Diagnostics Market Analysis

    Posted July 15, 2022

    The use of infectious disease diagnostics kits, assays, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives. The increasing investments by healthcare companies to meet i...

View All Entries

Forum Posts

  • January 18, 2023 2:53 AM EST
    in the topic Digital PCR Market Potential Growth& Forecasts to 2032 in the forum News and Announcements
    Digital PCR has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of disease diagnosis. Most players in the global digital PCR market offer products, such as kits and assays, systems, and reagents and consumables. The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consumables. The unexpected crisis of the pandemic has surged the demand for essentials and increased the demand for digital PCR products. There was increased demand for digital PCR from biotechnology and life sciences companies. Overall, the impact of COVID-19 on the global d-PCR market size has been low-moderate. Some market players have reported a slight decline in sales. However, some new entrants in the global d-PCR market are expected to witness growth in the market. There is also a decline in revenues mostly due to the initial phases of the COVID-19 pandemic, which comprised complete lockdowns across countries and major cities, thereby interrupting the supply chain. Several other products have been under development for years that may take longer than 2–4 years for commercialization. The pandemic has played a key role in enhancing the growth prospects of digital PCR-based diagnostics and is expected to indirectly aid in improving the market growth outlook. The BIS Research report on the global digital PCR market segments the market based on the following: Product (systems, kits and assays, reagents and consumables) Application (oncology, infectious disease, rare diseases, reproductive genetics, and other applications), End user (academic and research institutions, diagnostics centers, hospitals and clinics and biopharmaceutical companies) Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World). Recent Developments in the Global Digital PCR Market • In March 2022, Stilla signed an agreement with 12 distributors throughout EMEA. This agreement grants distribution rights to Stilla’s full product portfolio, including the six-color naica system.• In April 2022, Stilla and Promega Corporation signed a co-marketing agreement to offer a complete digital PCR workflow solution to provide their end users with optimized workflow for a wide range of applications, including liquid biopsy, sentinel pathogen testing, infectious disease assay, overall cancer research, and drug discovery.• In October 2021, Bio-Rad Laboratories, Inc. acquired Dropworks, Inc., a development stage company focused on developing a digital PCR product. The strategy was to increase and complement the company’s life sciences product offerings.• In September 2021, Thermo Fisher Scientific launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results. Digital PCR Market Segmentation Demand — Drivers and Limitations Following are the demand drivers for the global digital PCR market: • Technological Transformations Related to Digital PCR• Rising Adoption of Digital PCR among Various Applications• Increasing Activities in d-PCR Ecosystem The market is expected to face some limitations too due to the following challenges: • Higher Cost of Droplet Digital PCR• Presence of Opaque Regulatory Framework   Key Market Players and Competition Synopsis The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration. Some prominent names established in this market are: • Bio-Rad Laboratories, Inc.• Fluidigm Corporation• F. Hoffmann-La Roche Ltd.• Merck KGaA• QIAGEN N.V.• Thermo Fisher Scientific Inc.• Genetron Holdings Limited• JN Medsys• Stilla• Naveris, Inc.• SAGA Diagnostics Get Free Sample Report — https://bisresearch.com/requestsample?id=1348type=download Key Questions Answered in the Report How is digital PCR revolutionizing the field of genomics? What are the major market drivers, challenges, and opportunities in the global digital PCR market? What are the underlying structures resulting in the emerging trends within the global digital PCR market? How did the COVID-19 pandemic impact the global digital PCR market? What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market? What are the key regulatory implications in developed and developing regions pertaining to the use of digital PCR? What are the potential entry barriers that are expected to be faced by the companies willing to enter a particular region? How is each segment of the market expected to grow during the forecast period 2022–2032, and what is the anticipated revenue to be generated by each of the segments? BIS Related Studies Molecular Diagnostics Market — A Global and Regional Analysis Global Molecular Diagnostics Point of Care Market
  • December 29, 2022 8:02 AM EST
    in the topic Cell and Gene Therapy Market Current Growth in the forum News and Announcements
    Cell and gene therapy are overlapping fields of biomedical research having similar therapeutic goals, which target DNA or RNA inside or outside the body. Both therapies aim at modifying genetic material for treatment of a disease. Gene therapy uses genetic material, or DNA, to manipulate a patient’s cells for the treatment of an inherited or acquired disease. Cell therapy is the introduction of new cells into a patient’s body to grow, replace or repair damaged tissue to treat a disease. The cell and gene therapies are categorized into several therapeutic class, such as rare diseases, oncology, hematology, cardiovascular, ophthalmology, neurology, and others. The global cell and gene therapy market was valued at $2,599.7 million in 2020, and it is expected to grow at an impressive double-digit rate of 33.82% and reach a value of $25,002.1 million in 2027. The existing cell and gene therapy market is favored by multiple factors, which include increasing incidences of cancer and other chronic diseases, rising number of clinical trials, increasing funding and investments in the cell and gene therapy market, and favorable regulatory environment and FDA Approvals for cell and gene therapy products. View the Report on BIS Research - Global Cell and Gene Therapy Market Competitive Landscape The global cell and gene therapy market witnessed 14 mergers and acquisitions, 14 product launches and approvals, 13 joint ventures, and nine business expansions. 14 mergers and acquisitions, 14 product launches and approvals, 13 joint ventures, and nine business expansions. Major players within the cell and gene therapy market are Amgen Inc., bluebird bio, Inc., Castle Creek Pharmaceutical Holdings., Kite Pharma, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Spark Therapeutics, Inc., Vericel Corporation, Dendreon Pharmaceuticals LLC., Human Stem Cells Institute, Kolon TissueGene, Inc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co. Ltd., and Sibiono GeneTech Co. Ltd. Market Segmentation • By Product Type: Yescarta, Provenge, Luxtura, Kymriah, Imlygic, Gintuit, MACI, Laviv, Gendicine, Oncorine, Neovasculgen, Strimvelis, Invossa, Zolgenesma, Tecartus, Liso-Cel, Zyntelego, Others • By Therapeutic Class: Rare Diseases, Oncology, Hematology, Cardiovascular, Ophthalmology, Neurology and Other Therapeutic Classes • By Region: North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World Regional Segmentation • North America – Country Specific Stratification • Europe – Country Specific Stratification • Asia-Pacific – Country Specific Stratification • Latin America – Country Specific Stratification • Rest-of-the-World  Cell and Gene Therapy Market Dynamics     Key Cell and Gene Therapy Companies Profiled Amgen Inc., bluebird bio, Inc., Castle Creek Pharmaceutical Holdings., Kite Pharma, Inc., Novartis AG, Orchard Therapeutics plc., Pfizer, Inc., Spark Therapeutics, Inc., Vericel Corporation, Dendreon Pharmaceuticals LLC., Human Stem Cells Institute, Kolon TissueGene, Inc., Organogenesis Holdings Inc., Pfizer, Inc., RENOVA THERAPEUTICS, Shanghai Sunway Biotech Co. Ltd., and Sibiono GeneTech Co. Ltd.   Key Questions Answered in this Report: •    What are the different types of approved cell and gene therapies available in the respective market?•    What are the key development strategies implemented by the key players to stand out in this market?•    What are the various manufacturing considerations within the cell and gene therapy market?•    How have the strategic collaborations among the key players providing a push to product development within the global cell and gene therapy market? •    What are the regulations pertaining to the global cell and gene therapy market in different regions?•    What are the initiatives implemented by different government bodies regulating the development and commercialization of cell and gene therapy products and associated platforms?•    How has COVID-19 impacted the cell and gene therapy market?•    How will the urgency of the pandemic influence the global cell and gene therapy market?•    What are the leading companies dominating the global cell and gene therapy market?•    What is the reimbursement scenario of the products offered in the global cell and gene therapy market?•    Based on the product type, which therapy in the global cell and gene therapy market is anticipated to witness a massive rise in demand in the forecast period?•    How is each segment of the global cell and gene therapy market expected to grow during the forecast period, and what is the revenue expected to be generated by each of the segments by the end of 2027? Get Free Sample Report - https://bisresearch.com/requestsample?id=1062type=download Within the research report, the market is segmented on the basis of product type (Yescarta, Provenge, Luxtura, Kymriah, Imlygic, Gintuit, MACI, Laviv, Gendicine, Oncorine, Neovasculgen, Strimvelis, Invossa, Zolgenesma, Tecartus, Liso-cel, Zyntelego, Others), therapeutic class type (Yescarta, Provenge, Luxtura, Kymriah, Imlygic, Gintuit, MACI, Laviv, Gendicine, Oncorine, Neovasculgen, Strimvelis, Invossa, Zolgenesma, Tecartus, Liso-cel, Zyntelego, Others), and region (North America, Europe, Asia Pacific, Latin America, and Rest-of-the-World). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, and future opportunities, among other analyses, to detail the scope and provide a 360-coverage of the domain. BIS Research Related Market Studies: Global CRISPR Gene Editing Market - Analysis and Forecast, 2020-2030
  • December 16, 2022 2:37 AM EST
    in the topic Endoscopic Imaging Systems Market Future Outlook 2030 in the forum News and Announcements
    The adoption of artificial intelligence (AI) in endoscopic procedures and the entry of local companies into the regional endoscopic imaging systems market are significant opportunities in the global endoscopic imaging systems market. Moreover, the increasing demand in developing regions is also an opportunity for market growth. The global endoscopic imaging systems market is projected to reach $6.94 billion in terms of revenue by 2030, at a CAGR of 7.43%, suggests the premium market intelligence study by BIS Research. The comprehensive study of the global endoscopic imaging systems market by BIS Research extensively covers the market numbers based on the types of applications and region. It analyzes 15 companies offering endoscopic imaging systems along with a detailed global and regional market analysis, including the scrutiny of 10 key countries. Recent Developments in Global Endoscopic Imaging Systems Market •    In October 2021, Fujifilm Healthcare Americas Corporation established its new El-740D/S dual-channel endoscope, an FDA-approved dual-channel endoscope that can be applied in upper and lower gastrointestinal areas.•    In August 2021, Boston Scientific Corporation received the U.S. Food and Drug Administration (FDA) approval for its Exalt B single-use bronchoscope.•    In August 2021, KARL STORZ Endoscopy-America, Inc., a subsidiary of KARL STORZ SE Co. KG, launched the newer version of the TELE PACK+ compact endoscopy system. After the update, the endoscopy system can be linked with StreamConnect for networking and data management.•    In July 2021, Fujifilm Medical Systems U.S.A., Inc. received the U.S. FDA approval for its ELUXEO Surgical System, an oxygen saturation endoscopic imaging system.•    In June 2021, HOYA Corporation's subsidiary PENTAX Medical established a joint venture partnership with Jiangsu Vedkang Medical Science and Technology to make single-use flexible medical endoscopic therapeutic products.•    In May 2021, Boston Scientific Corporation received CE mark approval for its Exalt B single-use bronchoscope.•    In April 2021, Olympus Corporation launched a new line of endoscopes known as the H-SteriScopes, including five new single-use bronchoscopes.•    In February 2021, Olympus Corporation acquired Quest Photonic Devices. Through this acquisition, the company broadened its offerings for endoscopy devices.•    In October 2020, Ambu A/S/ partnered with a prominent U.S. Group Purchasing Organization (GPO) to develop single-use endoscopes for various medical specialties.    Market Segmentation: Segmentation 1: by Application•    Therapeutic Endoscopic Imaging Systems•    Diagnostic Endoscopic Imaging Systems The global endoscopic imaging systems market in the application segment is expected to be dominated by the diagnostic endoscopic imaging systems segment during the forecast period 2022-2030. Segmentation 2: by Region•    North America: U.S., Canada•    Asia-Pacific: Japan, South Korea, India, Rest-of-Asia-Pacific•    Europe: Germany, France, U.K., Italy, Spain, Rest-of-Europe•    Commonwealth of Independent States (CIS)•    China•    Latin America•    Middle East and Africa The North America and Europe region are expected to witness the maximum growth during the forecast period, followed by the Asia-Pacific region, which is expected to grow at the fastest rate. Furthermore, despite a few challenges, such as the shortage of skilled professionals for endoscopic imaging procedures and the lack of reimbursement systems in underdeveloped countries, the global endoscopic imaging systems market will continue to grow. Asia-Pacific to be the Fastest-Growing Regional Market in Global Endoscopic Imaging Systems Market In terms of region, the global endoscopic imaging systems market is segmented into North America, Europe, Asia-Pacific, China, CIS Region, Latin America, and Middle East Africa. Impact of COVID-19 The COVID-19 pandemic was an unprecedented event in the global healthcare system. Healthcare systems in various economies collapsed, and technology integration skyrocketed. The endoscopic procedures were impacted similarly during the initial phase of the pandemic. Several non-emergency procedures were delayed or canceled to minimize infection risk during the early months of 2020. Similar to other medical specialties, the adoption rate was also negatively impacted in endoscopic imaging systems. The limited demand for new devices, high costs of endoscopic imaging systems, and disrupted supply chain were the major factors that hampered the production and sales of endoscopic imaging systems, specifically during the peak pandemic in 2020. Demand – Drivers and Limitations Following are the demand drivers for the global endoscopic imaging systems market: Growing adoption of minimally invasive procedures Improving clinical quality standards of the endoscopic procedures Growing technology integration in endoscopic imaging systems The market is expected to face some limitations too due to the following challenges: Dearth of skilled professionals Lack of reimbursement system in developing countries   Analyst's Take on the Market: According to Abdul Wahid, Principal Consultant – BIS Research, "Endoscopy is one of the medical specialties that have witnessed significant advancements. Its market will continue to grow considerably during the forecast period due to the increasing demand for minimally invasive procedures and the improving clinical quality standards for endoscopic procedures. The evolution in endoscopy appears to be paradigm-altering and can improve the recovery quality of the patients." View the report on - Global Endoscopic Imaging Systems Market Key Companies Operating in the Market and Competitive Landscape The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration. Some prominent players in this market are: Ambu A/S Arthrex, Inc. B. Braun Melsungen AG Boston Scientific Corporation CONMED Corporation Fujifilm Holdings Corporation HOYA Corporation Johnson Johnson KARL STORZ SE  Co. KG Olympus Corporation Richard Wolf GmbH Smith Nephew Plc SonoScape Medical Corp.  Stryker Corporation Xion GmbH Request a Sample of this Report- https://bisresearch.com/requestsample?id=1324&type=download   Key Questions Answered in the Report What is the projected market size for the global endoscopic imaging systems market by the end of 2030? Furthermore, what is the projected global installed base of the systems by the end of 2030? How do the regulations in various regions impact the regional and global endoscopic imaging systems market? What was the impact of COVID-19 on the growth of the global market? What is the patent filing trend for the global endoscopic imaging systems market? Which key companies have been involved in the patent filing from 2019 to 2021? Who are the key players in the global endoscopic imaging systems market? What was the market share of the companies in 2021? Which strategy is most widely adopted by the companies in the global endoscopic imaging systems market for strengthening their foothold in the market? What are the key market drivers and restraints that influence the global endoscopic imaging systems market? What is their impact in the short, mid, and long term? What is the projected market size of the diagnostic and therapeutic endoscopic imaging systems by the end of 2030? Furthermore, which segment is projected to grow with the highest CAGR during the forecast period 2022-2030? What is the pricing framework of the endoscopic imaging systems across various regions? How does this influence the installed base in the regional markets and consequently their market size? Which regional market is projected to grow with the highest CAGR during the forecast period 2022-2030?  The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of endoscopic imaging systems BIS Research Related Market Studies: Medical Grade Tubing Market
  • December 15, 2022 5:47 AM EST
    in the topic PD-1/PDL-1 Inhibitor Market Growth Estimate & Strategy in the forum News and Announcements
    Programmed cell death 1 (PD-1) inhibitor and programmed death ligand 1 (PD-L1) inhibitor are therapeutic agents that inhibit binding together of these checkpoint proteins on immune cells, eventually preventing tumors to escape the host immune defense mechanism and control the disease progression. The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has been found to be more effective in patients demonstrating certain level of predictive biomarkers such as PDL-1 expression. However, these tests are costly and treatment specific which poses a hinderance to smooth administration of these PD-1/PDL-1 inhibitors to larger set of patients. Several players, such as MSD, Bristol Myers Squibb company (BMS), AstraZeneca Plc are among the leading companies actively pursuing research activities in maximizing the potential of PD-1/PDL-1 inhbitors. Companies in the Asia-Pacific region also have rich clinical pipeline and strategically pursuing research activities in this segment. Segmentation: Within the research report, the segmentation has made on the basis of: •    Identified cancer indicattions (Non-small cell lung cancer, melanoma, breast cancer, hepatocellular carcinoma, colorectal cancer, and urothelial carcinoma), and•    The seven major markets (the U.S., the U.K., Germany, France, Italy, Spain, and Japan). This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, and future opportunities, among others, to detail the scope and provide a 360-coverage of the domain. Demand – Drivers and Challenges Some of the potential drivers identified by BIS Research includes: •    Increased Use of PD-1/PDL-1 Inhibitors in Multiple Sub-set of Cancer Indications•    Increase in PD-1/PDL-1 Inhibitor Based Combination Regimens The market is expected to face some limitations too due to the following challenges: •    Immune-related Adverse Events Associated With PD-1/PDL-1 Inhibitor Treatment are a Cause of Concern•    Treatment Specific Biomarkers Assays Pose Hinderance to Smooth Adoption of PD-1/PDL-1 Inhibitor Treatment Competitive Landscape There are seven product currently available in the market. The first entrant Keytruda drwas a significant share of the market followed by second entrant Opdivo. Imfinzi and Tecentriq also have their combined market share below 20%. Disease Landscape In terms of most promising indication for the application of PD-1/PDL-1 inhibitors, melanoma appears to be leading as highlighted by experts including data gathered from secondary research. Analyst Thoughts According to Tausif, Principal Analyst, BIS Research, “Global PD-1/PDL-1 inhibitor market is expected to grow further in the coming years as more and more research activities are being pursued toward bringing more and more cancer indications under the treatment purview of PD-1/PDL-1 inhibitors and other relevant strategies being worked-upon by involved companies to maximize the potential of these agents”. Key Questions Answered in the Report What are PD-1/PDL-1 inhibitors? How have PD-1/PDL-1 inhibitors evolved over the years since their inception? What are the major market drivers, challenges, and opportunities in the global PD-1/PDL-1 inhibitors market? What are the potential indications being investigated for PD-1/PDL-1 inhibitors? What does the pipeline for the PD-1/PDL-1 inhibitors market look like? What are the key development strategies implemented by the major players in order to sustain them in the competitive market? What is the target patient pool for PD-1/PDL-1 inhibitors in promising cancer indications? How is the patient pool in each cancer indication expected to grow during the forecast period 2022-2032? Get Free Sample Report - https://bisresearch.com/requestsample?id=1357type=download The aim of this research study is to identify potential patients eligible to receive PD-1/PDL-1 inhibitor treatment. The report includes approved indications with PD-1/PDL-1 Inhibitors along with number of clinical trials being performed using PD-1/PDL-1 Inhibitor as primary treatment. The USP of this report The following can be seen as some of the USPs of the report: · Epidemiology forecast, underlining estimated target patient population eligible to receive PD-1/PDL-1 inhibitor treatment · Extensive competitive benchmarking of 14 key companies with their offerings in the global PD-1/PDL-1 inhibitor market · A peek-into market dynamics of global PD-1/PDL-1 inhibitor market The study also presents an in-depth analysis of the drivers, restraints, and opportunities of the market playing a significant role in major countries of North America, Europe, and Asia-Pacific. Who should buy this report? This report will help companies involved in research and development of PD-1/PDL-1 inhibitors to understand the opportunity as well as competition in the segment as well it help venture capital investment firms to make informed decisions on their investment in PD-1/PDL-1 inhibitor therapeutics segment. BIS Related Studies Global PD-1/PD-L1 Immunotherapy Market
  • December 8, 2022 3:00 AM EST
    in the topic AI in Healthcare Market Growth Analysis in the forum News and Announcements
    AI-enabled devices are used for augmenting care delivery, data management, diagnosis, and research, among other healthcare operations. Various technologies such as big data, augmented intelligence, multi-model data management, and artificial intelligence (AI), are being used for efficient data management. However, AI adoption is anticipated to be highest among all the data management technologies. Moreover, AI technology is anticipated to enhance the efficacy of clinician workflow, decision-making process, and administration workflow.  The global AI in healthcare market is anticipated to reach $35,892.2million by 2030, registering a CAGR of 24.40%, during the forecast period 2021-2030. Owing to the COVID pandemic, the market grew with a significant growth rate in 2020. The global lockdown and social distancing norms highlighted the importance of remote monitoring, telemedicine, and technology integration in the primary healthcare system, which accelerated the market growth in 2020. The following figure represents the global AI in healthcare market during 2019-2030. Presently, AI adoption is high in few healthcare applications such as medical diagnosis and imaging, and data management. Moreover, AI adoption is being encouraged in telemedicine, remote monitoring and lifestyle management, and robot-assisted surgery.  COVID-19 Impact on Global AI in Healthcare Market The onset of the COVID-19 pandemic has encouraged AI adoption in the global healthcare paradigm. The adoption of this technology has increased in developed and developing economies. However, lack of specific regulations and limited efficacy of AI in clinical environment is anticipated to limit AI adoption by the healthcare systems. Few of the key developments completed during the COVID-19 pandemic are as follows: Infervision Medical Technology Co., Ltd, a China-based company, launched an AI-enabled diagnosis solution for COVID-19 in 2020. K Health, an Israel-based telemedicine company, raised $48 million in funding in February 2020. The company intends to utilize the funding for releasing telemedicine services in Spanish. Market Dynamics Market Growth Opportunities Enabling Care at Home: Remote Monitoring AI integrated devices are making remote monitoring of patients feasible. AI integrated devices linked with mobile applications track and share medical data with physicians and suggest necessary action depending upon the patient situation. For instance, digital applications integrated with AI-enabled blood glucose monitors enable physicians to track the blood glucose levels of patients remotely. AI-enabled wearable devices such as smartwatches connected with digital applications can constantly track health vitals, enabling better lifestyle management. • Capitalizing on Unmet Clinical Demand• Leveraging Rapid Development in Deep Learning• Unlocking the Combined Potential of AI and Robotics Market Restraints • Lack of Clearly Defined Regulations• Data Security and Privacy Concerns• Barriers to Physician’s Adoption of AI• Legal Implications of AI Systems Opportunity Analysis Developing countries such as China and India are anticipated to significantly benefit from the increasing acceptance by healthcare providers and patients regarding the adoption of AI-enabled healthcare solutions. Companies across the globe, as well as potential new entrants, are anticipated to target the developing countries as they remain largely untapped, especially in the case of healthcare applications such as telemedicine, remote monitoring, robot-assisted surgery, patient and provider data management, which have strong potential for future growth. Thus, with a growing preference for advanced technologies in developing countries, the market competition is likely to intensify, wherein leading companies are anticipated to differentiate their solutions based on the pricing and delivery models. Key Companies in the Global AI in Healthcare Market   Some of the key players contributing to the global AI in Healthcare market include Activ Surgical, Inc., Atomwise, Inc., Babylon Health, BenevolentAI, Butterfly Network, Inc., Freenome, General Electric Company, International Business Machines Corporation (IBM), Koninklijke Philips N.V., Nuance Communications, Inc., Nvidia Corporation, Olive, Siemens Healthineers AG, Viz.ai, Inc., and Zebra Medical Vision Ltd.   Key Questions Answered in this Report: • What are the key regulations governing AI adoption in healthcare across various regions?• Which start-ups received significant funding in 2020?• What has been the impact of the COVID-19 pandemic on global AI in healthcare market?• What is the anticipated futuristic impact of COVID-19 on AI adoption in the global healthcare market?• What are the opportunities for AI healthcare startups in healthcare sector during the COVID-19 pandemic?• Who are the leading players in global AI in healthcare market?• What are the key business models prevalent in global AI in healthcare market?• What type of products are anticipated to be launched during the forecast period 2021-2030?• What are the key market drivers, restraints, and growth opportunities for the market?• What was the market size for the various product types in the global AI in healthcare market in 2020? How are the product types anticipated to grow during the forecast period 2021-2030?• What was the market size for various AI-enabled applications in healthcare in 2020? Which application is anticipated to grow with the highest CAGR during the forecast period 2021-2030?• What was the market size of AI technologies, such as machine learning, deep learning, natural language processing, and computer vision in 2020? How are the technologies anticipated to grow during the forecast period, 2021-2030?• Which region contributes the major share to the global AI in healthcare market? Which region holds significant growth potential during the forecast period 2021-2030? Get Free Sample Report - https://bisresearch.com/requestsample?id=1068type=downl... Key USPs of the Report Following are some of the key contents of the report: •    Funding Scenario This section encompasses a description of the current funding landscape in the global AI in healthcare space for key players. •    Technology Readiness Index This section is intended to aid the readers in identifying novel technology opportunities.  •    Business Model Analysis This section comprises information on the key business models deployed in the market by leading players. BIS Related Studies Global Next Generation Implants (NGI) Market – Analysis and Forecast (2017-2023)
Previous
Next
Copyright ©2024  -  Privacy  -  Terms of Service  -  Contact  -  Mobile Site

Create Account

You will use your email address to login.

 
 

Member Sign In

If you already have an account, please enter your details below. If you don't have one yet, please sign up first.

 
 
 
Forgot Password?
Share